Pharmaceutical

STALICLA appoints Dr. Purnanand Sarma, PhD, as Chair of the Board of Directors

Sarma1 2 Dr. Purnanand Sarma, PhD Press Release Dr. Sarma brings exceptional expertise in all facets of the pharmaceutical and…

1 year ago

Invitation to Cosmo’s Half-Year 2024 Webcast on 24 July 2024

Dublin, Ireland--(Newsfile Corp. - July 9, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announced today that it…

1 year ago

Porton J-STAR and Enabling Technologies Consortium Collaboration on Co-processing Platform Technology Development

CHONGQING, China, July 8, 2024 /PRNewswire/ -- Porton J-STAR today announced that Enabling Technologies Consortium (ETC) has awarded a two-year…

1 year ago

GE HealthCare to announce second quarter 2024 results on July 31, 2024

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, will announce its second…

1 year ago

GE HealthCare to announce second quarter 2024 results on July 31, 2024

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, will announce its second…

1 year ago

CBIH: Unleashing the Potential of Cannabis for Tomorrow’s Medicine

A letter from our deskHouston, Texas--(Newsfile Corp. - July 8, 2024) - Since the start of the year, Cannabis Bioscience…

1 year ago

Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762

Five sites across the U.S. are now participating in the Phase 1b study Marlborough, Massachusetts--(Newsfile Corp. - July 8, 2024)…

1 year ago

FloraWorks Appoints Dr. Matthew Roberts as Chief Operating Officer to Drive Next Phase of Growth

Portland, Oregon--(Newsfile Corp. - July 8, 2024) - FloraWorks, a leading innovator in the development and commercialization of cannabinoid therapeutics,…

1 year ago

Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz

Just - Evotec Biologics expands partnership with Sandoz for development and commercial manufacturing of biosimilarsAdditional biosimilars potentially to be added…

1 year ago

SELLAS Receives European Medicines Agency Orphan Drug Designation for SLS009 for the Treatment of Acute Myeloid Leukemia

NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a…

1 year ago